搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
1 天
Amylyx Pharmaceuticals (AMLX): Leading Nano Cap in Neurodegenerative Disease Treatments
We recently published a list of 7 Best Nano Cap Stocks To Invest In. In this article, we are going to take a look at where ...
News Medical
2 天
New glucose-sensitive insulin NNC2215 could transform diabetes care by lowering ...
NNC2215, a glucose-sensitive insulin, offers improved glycemic control by dynamically adjusting to blood sugar levels, ...
ThePrint
3 天
Danish scientists create ‘smart’ insulin with ‘on-off’ switch to target blood sugar ...
Novo Nordisk scientists have synthesised an insulin molecule that specifically targets glucose in blood, instead of other sugars like fructose, to aid treatment of all types of diabetes.
New Atlas
4 天
‘Insulin with a switch’ will help diabetics avoid dangerous hypos
An insulin that switches itself on and off in response to blood glucose levels has proven successful in lowering the risk of ...
5 天
on MSN
Soleno Therapeutics (SLNO): Breakthroughs in Prader-Willi Syndrome Treatment
We recently published a list of 10 Most Promising Small-Cap Stocks According to Hedge Funds. In this article, we are going to ...
ophthalmologyadvisor
5 天
Once-Weekly Insulin Inferior to Tirzepatide for Glycemic Control, Weight Loss
Once-weekly insulin vs once-weekly tirzepatide demonstrated superior safety profiles but inferior weight loss and glycemic control outcomes.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈